VoICE Immunization Evidence

Economic evaluation of pneumococcal conjugate vaccination in The Gambia

Authored by: Kim, S., Lee, G. and Goldie, S.

Appears in:

Key Idea

Assuming 90% coverage, a program in The Gambia using a 9-valent PCV (PCV9) would prevent approximately 630 hospitalizations, 40 deaths, and 1000 DALYs, over the first 5 years of life of a birth cohort. The estimated cost would be $670 per DALY averted in The Gambia.

Key Idea

Assuming 90% coverage, a program in The Gambia using a 9-valent PCV (PCV9) would prevent approximately 630 hospitalizations, 40 deaths, and 1000 DALYs, over the first 5 years of life of a birth cohort. The estimated cost would be $670 per DALY averted in The Gambia.

Published In

Kim, S., Lee, G. and Goldie, S. 2010. Economic evaluation of pneumococcal conjugate vaccination in The Gambia. BMC Infectious Diseases. 10:260.